Abattis Subsidiary, Northern Vine, Provides Update on Growth Targets (PR)

1 Response Abattis News | Northern Vine | Raybot

VANCOUVER, British Columbia / GLOBE NEWSWIRE / Aug. 23, 2017 Abattis Bioceuticals Corp. (the “Company” or “Abattis”) (CSE:ATT) (ATTBF) is pleased to provide an update on its subsidiary, Northern Vine Canada Inc. (“Northern Vine”), which specializes in the legal testing and analysis of cannabis products and is expected to soon commence extraction of cannabinoid derivatives […]

Abattis Announces the Official Launch of Northern Vine Laboratory (PR)

6 Responses Abattis News | Health Canada | Northern Vine | Raybot

Vancouver, British Columbia / Newsfile Corp / May 3, 2017 Abattis Bioceuticals Corp. (OTCQB: ATTBF) (CSE: ATT) (the “Company” or “Abattis“) is pleased to announce that its subsidiary, Northern Vine Canada Inc. (“Northern Vine“), has officially launched its flagship laboratory, having completed its first successful test analysis. “I am very pleased to announce this significant […]

Canada’s Plans for Near-term Legalization Puts Testing into Focus (CFN Media)

0 Responses Abattis News | Northern Vine

SEATTLE, WA / Marketwired / Apr 4, 2017 CFN Media Group, the leading creative agency and digital media network dedicated to legal cannabis, announces the publication of an article discussing the planned legalization of cannabis in Canada, the growing and urgent need for testing in both the existing and upcoming legal cannabis markets, and Abattis […]

Abattis Welcomes Dr. David Galvez as Science Advisor to Northern Vine (PR)

0 Responses Abattis News | Northern Vine

VANCOUVER, BC / ACCESSWIRE / March 20, 2017 Abattis Bioceuticals Corp. (ATTBF) (CSE:ATT) (the “Company” or “Abattis”) is pleased to announce that Dr. David Galvez, PhD, will be joining the team to lead Northern Vine’s Science Advisory efforts. Dr. Galvez received his doctorate in Plant Physiology at the University of Alberta and is a seasoned […]